National

Swiss surgeons perform Europe's first partial heart transplant on 12-year-old child

Oct 17, 2025

Geneva [Switzerland], October 17: The Geneva University Hospital (HUG) in Switzerland announced Thursday that its medical team has successfully carried out Europe's first partial heart transplant on a 12-year-old child with a complex congenital heart defect.
Performed in September, the groundbreaking operation involved transplanting only part of a donor heart, specifically the aortic and pulmonary valves, rather than replacing the entire organ. This innovative approach allows the transplanted valves to grow with the child, reducing the need for multiple surgeries and potentially offering a lifelong solution.
The procedure was led by paediatric cardiac surgeon Dr. Tornike Sologashvili and initiated by paediatric cardiologist Dr. Julie Wacker, who have been developing the hospital's partial heart transplantation program for the past two years.
According to HUG, the young patient is recovering well under medical supervision.
Since the technique was first introduced in 2022, only about 30 such transplants have been performed globally, all in the United States. The European first at HUG marks a major advance in paediatric cardiac surgery, offering new hope for children with selected congenital heart conditions.
Dr. Wacker highlighted the benefits of the technique, noting that by preserving the patient's own heart muscle, the risk of rejection is reduced, the need for immunosuppressive therapy is limited, and the implanted valves adapt as the child grows.
Source: Xinhua News Agency

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026